A Boston federal magistrate judge is allowing plaintiffs’ experts to conduct “destructive” testing, including inspection of walls and ductwork, at New England Compounding Pharmacy Inc., a company linked to a fungal meningitis outbreak that caused 37 deaths.
In addition, the federal judge running the consolidated docket of District of Massachusetts cases for pretrial purposes, In Re New England Compounding Pharmacy Cases, has remanded two of the cases back to state court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
